Abstract:Background: Streptomyces chattanoogensis L10 is the industrial producer of natamycin and has been proved a highly efficient host for diverse natural products. It has an enormous potential to be developed as a versatile cell factory for production of heterologous secondary metabolites. Here we developed a genome-reduced industrial Streptomyces chassis by rational 'design-build-test' pipeline. Results: To identify candidate large non-essential genomic regions accurately and design large deletion rationally, we performed genome analyses of S. chattanoogensis L10 by multiple computational approaches, optimized Cre/loxP recombination system for high-efficient large deletion and constructed a series of universal suicide plasmids for rapid loxP or loxP mutant sites inserting into genome. Subsequently, two genome-streamlined mutants, designated S. chattanoogensis L320 and L321, were rationally constructed by depletion of 1.3 Mb and 0.7 Mb non-essential genomic regions, respectively. Furthermore, several biological performances like growth cycle, secondary metabolite profile, hyphae morphological engineering, intracellular energy (ATP) and reducing power (NADPH/NADP(+)) levels, transformation efficiency, genetic stability, productivity of heterologous proteins and secondary metabolite were systematically evaluated. Finally, our results revealed that L321 could serve as an efficient chassis for the production of polyketides. Conclusions: Here we developed the combined strategy of multiple computational approaches and site-specific recombination system to rationally construct genome-reduced Streptomyces hosts with high efficiency. Moreover, a genome-reduced industrial Streptomyces chassis S. chattanoogensis L321 was rationally constructed by the strategy, and the chassis exhibited several emergent and excellent performances for heterologous expression of secondary metabolite. The strategy could be widely applied in other Streptomyces to generate miscellaneous and versatile chassis with minimized genome. These chassis can not only serve as cell factories for high-efficient production of valuable polyketides, but also will provide great support for the upgrade of microbial pharmaceutical industry and drug discovery.

Identification of A Novel Streptomyces Chattanoogensis L10 and Enhancing Its Natamycin Production by Overexpressing Positive Regulator Scnrii

Generation of the natamycin analogs by gene engineering of natamycin biosynthetic genes in Streptomyces chattanoogensis L10.

The Pleitropic Regulator Adpa(Ch) is Required for Natamycin Biosynthesis and Morphological Differentiation in Streptomyces Chattanoogensis

Identification of a secondary metabolism-responsive promoter by proteomics for over-production of natamycin in Streptomyces

Transcriptome-Based Identification of a Strong Promoter for Hyper-production of Natamycin in Streptomyces.

Bidirectional Regulation of AdpAch in Controlling the Expression of Scnri and Scnrii in the Natamycin Biosynthesis of Streptomyces Chattanoogensis L10.

Multiple transporters are involved in natamycin efflux in Streptomyces chattanoogensis L10.

Improvement of Natamycin Production by Engineering of Phosphopantetheinyl Transferases in Streptomyces Chattanoogensis L10.

Sigma Factor WhiGch Positively Regulates Natamycin Production in Streptomyces Chattanoogensis L10

Activation of Anthrachamycin Biosynthesis in Streptomyces Chattanoogensis L10 by Site-Directed Mutagenesis of Rpob

Genome Mining and Homologous Comparison Strategy for Digging Exporters Contributing Self-Resistance in Natamycin-Producing Streptomyces Strains

[ABC transporter SgnA/B promotes extracellular transport and efficient production of natamycin]

Improving the production of natamycin in Streptomyces natalensis HW-2 by L-valine feeding

Overproduction of lactimidomycin by cross-overexpression of genes encoding Streptomyces antibiotic regulatory proteins

Characterization of type II thioesterases involved in natamycin biosynthesis in Streptomyces chattanoogensis L10.

Characterization of LnmO as a pathway-specific Crp/Fnr-type positive regulator for leinamycin biosynthesis in Streptomyces atroolivaceus and its application for titer improvement

UV-ARTP-DES compound mutagenesis breeding improves natamycin production of Streptomyces natalensis HW-2 and reveals transcriptional changes by RNA-seq

Ribosome engineering and fermentation optimization leads to overproduction of tiancimycin A, a new enediyne natural product from Streptomyces sp. CB03234

Co-expression of a SARP Family Activator ChlF2 and a Type II Thioesterase ChlK Led to High Production of Chlorothricin in Streptomyces antibioticus DSM 40725

Rational Construction of Genome-Reduced and High-Efficient Industrial Streptomyces Chassis Based on Multiple Comparative Genomic Approaches.

Transcriptome-Guided Identification of Spra As A Pleiotropic Regulator in Streptomyces Chattanoogensis